The Journal of Allergy and Clinical Immunology
Volume 120, Issue 3 , Pages 544-550 , September 2007

Advances in asthma, allergy mechanisms, and genetics in 2006

  • Fred D. Finkelman, MD

      Affiliations

    • Division of Immunology, University of Cincinnati, Cincinnati, Ohio
    • ,
  • Donata Vercelli, MD

      Affiliations

    • Arizona Respiratory Center, University of Arizona Health Sciences Center, Tucson, Ariz
    • Corresponding Author InformationReprint requests: Donata Vercelli, Arizona Respiratory Center, University of Arizona Health Sciences Center, 1501 N Campbell Ave, Suite 2349, Tucson, AZ 85724-5030.

Received 7 May 2007 ,Revised 8 May 2007 ,Accepted 11 May 2007.

References 

  1. Lee KS, Park SJ, Kim SR, Min KH, Jin SM, Puri KD, et al. Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma. J Allergy Clin Immunol. 2006;118:403–409
  2. Lee SY, Cho JY, Miller M, McElwain K, McElwain S, Sriramarao P, et al. Immunostimulatory DNA inhibits allergen-induced peribronchial angiogenesis in mice. J Allergy Clin Immunol. 2006;117:597–603
  3. Cho JY, Miller M, McElwain K, McElwain S, Shim JY, Raz E, et al. Remodeling associated expression of matrix metalloproteinase 9 but not tissue inhibitor of metalloproteinase 1 in airway epithelium: modulation by immunostimulatory DNA. J Allergy Clin Immunol. 2006;117:618–625
  4. Hahn C, Islamian AP, Renz H, Nockher WA. Airway epithelial cells produce neurotrophins and promote the survival of eosinophils during allergic airway inflammation. J Allergy Clin Immunol. 2006;117:787–794
  5. Nassenstein C, Dawbarn D, Pollock K, Allen SJ, Erpenbeck VJ, Spies E, et al. Pulmonary distribution, regulation, and functional role of Trk receptors in a murine model of asthma. J Allergy Clin Immunol. 2006;118:597–605
  6. Perkins C, Wills-Karp M, Finkelman FD. IL-4 induces IL-13-independent allergic airway inflammation. J Allergy Clin Immunol. 2006;118:410–419
  7. Takayama G, Arima K, Kanaji T, Toda S, Tanaka H, Shoji S, et al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol. 2006;118:98–104
  8. Blumchen K, Gerhold K, Schwede M, Niggemann B, Avagyan A, Dittrich AM, et al. Effects of established allergen sensitization on immune and airway responses after secondary allergen sensitization. J Allergy Clin Immunol. 2006;118:615–621
  9. Akei HS, Brandt EB, Mishra A, Strait RT, Finkelman FD, Warrier MR, et al. Epicutaneous aeroallergen exposure induces systemic TH2 immunity that predisposes to allergic nasal responses. J Allergy Clin Immunol. 2006;118:62–69
  10. Miyahara S, Miyahara N, Matsubara S, Takeda K, Koya T, Gelfand EW. IL-13 is essential to the late-phase response in allergic rhinitis. J Allergy Clin Immunol. 2006;118:1110–1116
  11. Tamachi T, Maezawa Y, Ikeda K, Kagami S, Hatano M, Seto Y, et al. IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice. J Allergy Clin Immunol. 2006;118:606–614
  12. Chen CL, Wang SD, Zeng ZY, Lin KJ, Kao ST, Tani T, et al. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma. J Allergy Clin Immunol. 2006;118:105–112
  13. Kendall M, Mitchell TJ, Costigan G, Armitage M, Lenzo JC, Thomas JA, et al. Downregulation of IgE antibody and allergic responses in the lung by epidermal biolistic microparticle delivery. J Allergy Clin Immunol. 2006;117:275–282
  14. Lee KS, Kim SR, Park SJ, Park HS, Min KH, Jin SM, et al. Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxia-inducible factor 1alpha in allergic airway disease of mice. J Allergy Clin Immunol. 2006;118:120–127
  15. Munitz A, Bachelet I, Levi-Schaffer F. Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. J Allergy Clin Immunol. 2006;118:1082–1089
  16. Shore SA, Terry RD, Flynt L, Xu A, Hug C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol. 2006;118:389–395
  17. Ferrara TJ, Mueller C, Sahu N, Ben-Jebria A, August A. Reduced airway hyperresponsiveness and tracheal responses during allergic asthma in mice lacking tyrosine kinase inducible T-cell kinase. J Allergy Clin Immunol. 2006;117:780–786
  18. Yamashita N, Tashimo H, Matsuo Y, Ishida H, Yoshiura K, Sato K, et al. Role of CCL21 and CCL19 in allergic inflammation in the ovalbumin-specific murine asthmatic model. J Allergy Clin Immunol. 2006;117:1040–1046
  19. Karagiannidis C, Hense G, Martin C, Epstein M, Ruckert B, Mantel PY, et al. Activin A is an acute allergen-responsive cytokine and provides a link to TGF-beta-mediated airway remodeling in asthma. J Allergy Clin Immunol. 2006;117:111–118
  20. Keller AC, Mucida D, Gomes E, Faquim-Mauro E, Faria AM, Rodriguez D, et al. Hierarchical suppression of asthma-like responses by mucosal tolerance. J Allergy Clin Immunol. 2006;117:283–290
  21. Vercelli D. Genetic regulation of IgE responses: Achilles and the tortoise. J Allergy Clin Immunol. 2005;116:60–64
  22. Vercelli D, Martinez FD. The Faustian bargain of genetic association studies: bigger might not be better, or at least it might not be good enough. J Allergy Clin Immunol. 2006;117:1303–1305
  23. Leynaert B, Guilloud-Bataille M, Soussan D, Benessiano J, Guenegou A, Pin I, et al. Association between farm exposure and atopy, according to the CD14 C-159T polymorphism. J Allergy Clin Immunol. 2006;118:658–665
  24. Williams LK, McPhee RA, Ownby DR, Peterson EL, James M, Zoratti EM, et al. Gene-environment interactions with CD14 C-260T and their relationship to total serum IgE levels in adults. J Allergy Clin Immunol. 2006;118:851–857
  25. Barnes KC, Grant A, Gao P, Baltadjieva D, Berg T, Chi P, et al. Polymorphisms in the novel gene acyloxyacyl hydroxylase (AOAH) are associated with asthma and associated phenotypes. J Allergy Clin Immunol. 2006;118:70–77
  26. Kawaguchi M, Takahashi D, Hizawa N, Suzuki S, Matsukura S, Kokubu F, et al. IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J Allergy Clin Immunol. 2006;117:795–801
  27. Kabesch M, Schedel M, Carr D, Woitsch B, Fritzsch C, Weiland SK, et al. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol. 2006;117:269–274
  28. Chan IH, Leung TF, Tang NL, Li CY, Sung YM, Wong GW, et al. Gene-gene interactions for asthma and plasma total IgE concentration in Chinese children. J Allergy Clin Immunol. 2006;117:127–133
  29. Maier LM, Howson JMM, Walker N, Spickett GP, Jones RW, Ring SM, et al. Association of IL13 with total IgE: Evidence against an inverse association of atopy and diabetes. J Allergy Clin Immunol. 2006;117:1306–1313
  30. Ober C, Thompson EE. Rethinking genetic models of asthma: the role of environmental modifiers. Curr Opin Immunol. 2005;17:1–9
  31. Cameron L, Webster RB, Strempel JM, Kiesler P, Kabesch M, Ramachandran H, et al. Th2-selective enhancement of human IL13 transcription by IL13-1112C>T, a polymorphism associated with allergic inflammation. J Immunol. 2006;177:8633–8642
  32. Weiss LA, Pan L, Abney M, Ober C. The sex-specific genetic architecture of quantitative traits in humans. Nat Genet. 2006;38:218–222
  33. Dijkstra A, Howard TD, Vonk JM, Ampleford EJ, Lange LA, Bleecker ER, et al. Estrogen receptor 1 polymorphisms are associated with airway hyperresponsiveness and lung function decline, particularly in female subjects with asthma. J Allergy Clin Immunol. 2006;117:604–611
  34. Zimmermann N, King N, Laporte J, Yang M, Mishra A, Pope SM, et al. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest. 2003;111:1863–1874
  35. Corne J, Chupp G, Lee CG, Homer RJ, Zhu Z, Chen Q, et al. IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest. 2000;106:783–791
  36. Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med. 2004;10:1095–1103
  37. Li H, Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, Estela del Rio-Navarro B, Kistner EO, et al. Genetic polymorphisms in arginase I and II and childhood asthma and atopy. J Allergy Clin Immunol. 2006;117:119–126
  38. Park HW, Lee JE, Shin ES, Lee JY, Bahn JW, Oh HB, et al. Association between genetic variations of vascular endothelial growth factor receptor 2 and atopy in the Korean population. J Allergy Clin Immunol. 2006;117:774–779
  39. Hoffjan S, Ostrovnaja I, Nicolae D, Newman DL, Nicolae R, Gangnon R, et al. Genetic variation in immunoregulatory pathways and atopic phenotypes in infancy. J Allergy Clin Immunol. 2004;113:511–518
  40. Mak JC, Leung HC, Ho SP, Law BK, Ho AS, Lam WK, et al. Analysis of TGF-beta(1) gene polymorphisms in Hong Kong Chinese patients with asthma. J Allergy Clin Immunol. 2006;117:92–96
  41. Tsai YJ, Choudhry S, Kho J, Beckman K, Tsai HJ, Navarro D, et al. The PTGDR gene is not associated with asthma in 3 ethnically diverse populations. J Allergy Clin Immunol. 2006;118:1242–1248
  42. Marenholz I, Nickel R, Ruschendorf F, Schulz F, Esparza-Gordillo J, Kerscher T, et al. Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol. 2006;118:866–871
  43. Blumenthal MN, Langefeld CD, Barnes KC, Ober C, Meyers DA, King RA, et al. A genome-wide search for quantitative trait loci contributing to variation in seasonal pollen reactivity. J Allergy Clin Immunol. 2006;117:79–85
  44. Kurz T, Hoffjan S, Hayes MG, Schneider D, Nicolae R, Heinzmann A, et al. Fine mapping and positional candidate studies on chromosome 5p13 identify multiple asthma susceptibility loci. J Allergy Clin Immunol. 2006;118:396–402

 Disclosure of potential conflict of interest: D. Vercelli served on the speakers' bureau for Merck. F. D. Finkelman has consultant arrangements with Amgen, Abbott, Plexxikon, Peptimmune, and Wyeth; has patent licensing arrangements with Becton-Dickinson and eBioscience; and has received research support from Amgen and Plexxikon.

PII: S0091-6749(07)00992-X

doi: 10.1016/j.jaci.2007.05.025

The Journal of Allergy and Clinical Immunology
Volume 120, Issue 3 , Pages 544-550 , September 2007

Article Tools

* Image Usage & Resolution